Phosphodiesterase 5 Inhibitor Use and Risk of Conventional and Serrated Precursors of Colorectal Cancer.

Yiwen Zhang Chun-Han LoEdward L Giovannucci

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)

We show that PDE5 inhibitor use is not associated with precursors of colorectal cancer adjusted for medical and lifestyle risk factors among a large population of men with 10 years of follow-up.

Keyphrases

risk factors
healthcare
metabolic syndrome
physical activity
cardiovascular disease
weight loss
middle aged
type diabetes